Publication

Brain imaging-based machine learning in autism spectrum disorder: methods and applications

Downloadable Content

Persistent URL
Last modified
  • 08/28/2025
Type of Material
Authors
    Ming Xu, Institute of Automation Chinese Academy of SciencesVince Calhoun, Emory UniversityRongtao Jiang, Institute of Automation Chinese Academy of SciencesWeizheng Yan, Georgia State UniversityJing Sui, Beijing Normal University
Language
  • English
Date
  • 2021-09-01
Publisher
  • Elsevier B.V.
Publication Version
Copyright Statement
  • © 2021 Elsevier B.V. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 361
Start Page
  • 109271
End Page
  • 109271
Grant/Funding Information
  • This work is supported in part by the National Natural Science Foundation of China (No. 82022035, 61773380), Beijing Municipal Science and Technology Commission (Z181100001518005), China; the National Institute of Health (1R01MH117107, R01EB005846, and P20GM103472), USA.
Abstract
  • Autism spectrum disorder (ASD) is a neurodevelopmental condition with early childhood onset and high heterogeneity. As the pathogenesis is still elusive, ASD diagnosis is comprised of a constellation of behavioral symptoms. Non-invasive brain imaging techniques, such as magnetic resonance imaging (MRI), provide a valuable objective measurement of the brain. Many efforts have been devoted to developing imaging-based diagnostic tools for ASD based on machine learning (ML) technologies. In this survey, we review recent advances that utilize machine learning approaches to classify individuals with and without ASD. First, we provide a brief overview of neuroimaging-based ASD classification studies, including the analysis of publications and general classification pipeline. Next, representative studies are highlighted and discussed in detail regarding different imaging modalities, methods and sample sizes. Finally, we highlight several common challenges and provide recommendations on future directions. In summary, identifying discriminative biomarkers for ASD diagnosis is challenging, and further establishing more comprehensive datasets and dissecting the individual and group heterogeneity will be critical to achieve better ADS diagnosis performance. Machine learning methods will continue to be developed and are poised to help advance the field in this regard.
Author Notes
  • J.Sui, State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China. Email: jsui@bnu.edu.cn
Keywords

Tools

Relations

In Collection:

Items